These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19864091)

  • 1. Inner ear involvement in Behçet's disease.
    Süslü AE; Polat M; Köybaşi S; Biçer YO; Funda YO; Parlak AH
    Auris Nasus Larynx; 2010 Jun; 37(3):286-90. PubMed ID: 19864091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cochlear involvement by distortion product otoacoustic emission in Behçet's disease.
    Dagli M; Eryilmaz A; Tanrikulu S; Aydin A; Gonul M; Gul U; Gocer C
    Auris Nasus Larynx; 2008 Sep; 35(3):333-7. PubMed ID: 17996415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distortion product otoacoustic emission findings in Behçet's disease and rheumatoid arthritis.
    Bayazit YA; Yilmaz M; Gunduz B; Altinyay S; Kemaloglu YK; Onder M; Gurer MA
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(4):233-8. PubMed ID: 17409782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hearing loss in patients with Behçet's disease: an audiological and transient evoked otoacoustic emission study.
    Aslan S; Serarslan G; Savas N; Teksoz E; Dagli S
    J Laryngol Otol; 2010 Jan; 124(1):10-5. PubMed ID: 19785925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outer hair cell activity of the cochlea in patients with iron deficiency anemia.
    Cetin T; Yetiser S; Cekin E; Durmus C; Nevruz O; Oktenli C
    Auris Nasus Larynx; 2004 Dec; 31(4):389-94. PubMed ID: 15571912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DPOAE in estimation of the function of the cochlea in tinnitus patients with normal hearing.
    Sztuka A; Pospiech L; Gawron W; Dudek K
    Auris Nasus Larynx; 2010 Feb; 37(1):55-60. PubMed ID: 19560298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distortion product otoacoustic emissions in an industrial setting.
    Korres GS; Balatsouras DG; Tzagaroulakis A; Kandiloros D; Ferekidou E; Korres S
    Noise Health; 2009; 11(43):103-10. PubMed ID: 19414930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cochlear involvement in Familial Mediterranean Fever: a new feature of an old disease.
    Koybasi S; Atasoy Hİ; Bicer YO; Tug E
    Int J Pediatr Otorhinolaryngol; 2012 Feb; 76(2):244-7. PubMed ID: 22177320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM; Feeney MP; Gates GA
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Applying distortion product otoacoustic emission in testing human sensory hearing loss].
    Chen X; Zheng H; Zheng Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):382-4. PubMed ID: 15181843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochlear origin of early hearing loss in vestibular schwannoma.
    Gouveris HT; Victor A; Mann WJ
    Laryngoscope; 2007 Apr; 117(4):680-3. PubMed ID: 17429875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of cochlear active mechanisms in tinnitus subjects with normal hearing sensitivity: multiparametric recording of evoked otoacoustic emissions and contralateral suppression.
    Paglialonga A; Del Bo L; Ravazzani P; Tognola G
    Auris Nasus Larynx; 2010 Jun; 37(3):291-8. PubMed ID: 19879078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Otoacoustic emissions in patients with hypotension.
    Balatsouras DG; Korres S; Simaskos N; Kandiloros D; Ferekidis E; Economou C
    J Laryngol Otol; 2003 Apr; 117(4):265-9. PubMed ID: 12816214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distortion-product otoacoustic emission spectra and high-resolution audiometry in noise-induced hearing loss.
    Avan P; Bonfils P
    Hear Res; 2005 Nov; 209(1-2):68-75. PubMed ID: 16112827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
    Telischi F
    Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cochlear function in facioscapulohumeral muscular dystrophy.
    Balatsouras DG; Korres S; Manta P; Panousopoulou A; Vassilopoulos D
    Otol Neurotol; 2007 Jan; 28(1):7-10. PubMed ID: 17106430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behçet's disease and hearing loss.
    AK E; Harputluoglu U; Oghan F; Baykal B
    Auris Nasus Larynx; 2004 Mar; 31(1):29-33. PubMed ID: 15041051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies of the evaluation of cochlea function with distortion product otoacoustic emission].
    Kashiwamura M
    Hokkaido Igaku Zasshi; 1998 Nov; 73(6):641-62. PubMed ID: 10036620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.